Intrinsic Value of S&P & Nasdaq Contact Us

Aptorum Group Limited APM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • GB • USD

SharesGrow Score
39/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Aptorum Group Limited (APM) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.

Analysts estimate Earnings Per Share (EPS) of $-0.70 and revenue of $0.03B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.78 vs est $-0.70 (missed -11.4%). 2025: actual $-0.19 vs est $1.10 (missed -117.3%). Analyst accuracy: 0%.

APM Analyst Ratings

Buy
2
Ratings
2 Buy
Based on 2 analysts giving stock ratings to Aptorum Group Limited in the past 3 months
Rating breakdown
Buy
2 100%
100%
Buy
2 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — APM

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.78 vs Est –$0.70 ▼ 10.3% off
2025 Actual –$0.19 vs Est $1.10 ▼ 678.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — APM

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message